Linsitinib (OSI-906) versus placebo for patients with...

The Lancet Oncology 2015 / 04 Vol. 16; Iss. 4

Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study

Fassnacht, Martin, Berruti, Alfredo, Baudin, Eric, Demeure, Michael J, Gilbert, Jill, Haak, Harm, Kroiss, Matthias, Quinn, David I, Hesseltine, Elizabeth, Ronchi, Cristina L, Terzolo, Massimo, Choueir
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
16
Language:
english
Journal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(15)70081-1
Date:
April, 2015
File:
PDF, 539 KB
english, 2015
Conversion to is in progress
Conversion to is failed